Wyndham Debuts First-of-its-Kind Travel Subscription with Day-One Payoffs

Wyndham Rewards Insider is your key to more points and perks with expansive travel savings, automatic Gold level status, double-dip points earning and more-all for just $95 a year Wyndham Rewards®, the #1-rated hotel rewards program known for its groundbreaking simplicity and generosity, is once again transforming the loyalty landscape with the launch of Wyndham […]

Innovative Health Earns the HIRC Resilience Badge

Innovative Health is the first reprocessor and the first small healthcare company receiving the badge, which confirms the company's adherence to high standards in its supply chain Innovative Health, Inc. today announced that the company achieved the HIRC Resiliency Badge, demonstrating the organization's commitment to resiliency within the healthcare supply chain. The badge is issued

Monster Energy’s Kim Lea Mueller Takes Second Place in Women’s BMX Park at UCI BMX Freestyle World Cup Shanghai

— 23-Year-Old Mueller from Germany Earns Podium Spot in Second Round of 2025 World Cup Season, Claims 3rd Place in Women's Pro BMX Freestyle Spine Ramp — 27-Year-Old French Olympic Medalist Anthony Jeanjean Claims 3rd Place in Men's BMX Park Huge weekend for BMX in Shanghai!Monster Energy congratulates team rider Kim Lea Muelleron taking second

Goldfish Gold Drives Accessible Tokenized Gold Investment, Launches Stablecoin

Goldfish Gold (GGBR Inc.) officially launches gold-backed stablecoin, offering liquidity, physical redemption options, and real-time price stability via proof-of-reserve oracles GGBR Inc., a Wyoming-based digital assets company, has announced the official public launch of its platform alongside the innovative Goldfish gold-backed stablecoin, following a long-term strategic partnership with I-ON Digital Corp. (“I-ON”), a leader in

MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("MoonLake" or "the Company") (NASDAQ:MLTX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

Star Hats & Embroidery Launches Holiday Deals on Custom Logo Hats and Beanies with Embroidery

Custom Embroidered Beanies Starting at $9.95 and Hats at $10.95 – Wholesale Pricing for Businesses and Brands Star Hats & Embroidery has introduced its Season Deals – Embroidered Hats and Beanies collection, offering businesses affordable, premium-quality custom embroidered headwear ahead of the holiday season. Custom embroidered beanies starting at $9.95 and custom embroidered hats starting

RADCOM to Report Third Quarter 2025 Earnings on Wednesday, November 12, 2025

RADCOM Ltd. (NASDAQ: RDCM)announced today that it will release its financial results for the third quarter, ended September 30, 2025, on Wednesday, 12, November, 2025 before the opening of trade on the Nasdaq Stock Market. RADCOM CEO Benny Eppstein and CFO Hadar Rahav will host a conference call and live webinar on the same day

Flare Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate FX-909 in Combination with KEYTRUDA(R) (pembrolizumab) in New Cohort of Ongoing Phase 1 Trial in Metastatic Urothelial Cancer

Flare Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate FX-909 in Combination with KEYTRUDA(R) (pembrolizumab) in New Cohort of Ongoing Phase 1 Trial in Metastatic Urothelial Cancer GlobeNewswire October 21, 2025 CAMBRIDGE, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to

HanchorBio Secures US Patent for Innovative SIRPa/CD47 Fusion Protein HCB101

HanchorBio today announced that its proprietary HCB101, a SIRPa/CD47 fusion protein candidate, has been officially granted a US patent (Patent No. 12,447,195) by the United States Patent and Trademark Office (USPTO). Titled “ENGINEERED SIRPa VARIANTS AND METHODS OF USE THEREOF”, the patent represents major international recognition for the company's innovative technology for immuno-oncology. Mechanism of

Altair Unlocks Next-Level HPC, AI, and Quantum Performance with Altair® HPCWorks® 2026

Enhancements to the industry-leading high-performance computing and cloud platform elevate next-generation computing Altair, a global leader in computational intelligence, today announced significant upgrades to theAltair® HPCWorks® high-performance computing (HPC) and cloud platform. The release of Altair HPCWorks 2026 enables faster discovery with new features and improvements including enhanced GPU integration and utilization, expanded AI and

Scroll to Top